Jonine Figueroa

Title: Jonine Figueroa: Innovator in Breast Cancer Biomarkers

Introduction

Jonine Figueroa is a prominent inventor based in Edinburgh, GB. She has made significant contributions to the field of cancer research, particularly in the identification of biomarkers for early detection of basal-like breast cancer. With a total of two patents to her name, her work is paving the way for advancements in cancer diagnostics.

Latest Patents

Figueroa's latest patents focus on plasma autoantibody biomarkers for basal-like breast cancer. Cancer patients produce antibodies to tumor-derived proteins, which serve as potential biomarkers for early detection. In her research, twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer. Additionally, a 13-AAb classifier has been developed to differentiate patients with basal-like breast cancer from healthy controls, achieving 33% sensitivity at 98% specificity.

Career Highlights

Throughout her career, Jonine Figueroa has worked with esteemed institutions such as Arizona State University and the National Institutes of Health, a component of the US Department of Health & Human Services. Her research has significantly impacted the understanding and early detection of breast cancer.

Collaborations

Figueroa has collaborated with notable colleagues, including Joshua LaBaer and Jie Wang, enhancing the depth and reach of her research efforts.

Conclusion

Jonine Figueroa's innovative work in identifying biomarkers for breast cancer detection exemplifies her commitment to advancing medical research. Her contributions are vital in the ongoing fight against cancer, and her patents reflect her dedication to improving patient outcomes.